Apotex Launches Rosuvastatin Calcium Tablets Generic Version Of AstraZeneca PLC's Crestor
WESTON, FL, July 22, 2016 /PRNewswire/ - Apotex Corp., announced today that it has launched Rosuvastatin Calcium Tablets, the generic equivalent of Crestor® by AstraZeneca.
Apotex's Rosuvastatin Calcium Tablets are now available in 5mg, 10mg, 20mg and 40mg strengths. According to IMS Health, Crestor® had approximately $6.6 billion in sales in the 12 months ending in January 2016.
Launching Rosuvastatin Calcium Tablets is just another example of how Apotex is everywhere. Making a difference. One life and product at a time.
About Apotex
Apotex Inc. is the 7th largest generic pharmaceutical company globally (according to IMS Health) with over 10,000 employees and estimated sales of approximately $2 billion. The company's US headquarters is based in Weston, Florida. With its worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. It produces 300 medicines in 4,000 dosages and formats that are exported to 120 countries. It has 300 products under development and will spend $2 billion over the next 10 years on research and development.
Contact: | Steve Giuli |
Director of Government Affairs & Industry Relations | |
(954) 224-5142 |
SOURCE Apotex Inc.
